As a pioneer in the global endeavor to develop effective treatments for an array of blood and immune disorders, the Stanford University School of Medicine (SoM) thrives on the pursuit of innovative research. Therefore, we are proud to introduce The Binns Program for Cord Blood Research, a joint effort initiated by the Pediatric Division of Stem Cell Transplantation and Regenerative Medicine and the Department of Obstetrics and Gynecology, which will serve as a resource to support Stanford University SoM research at the basic, translational, and clinical levels.
The mission of the Binns Program for Cord Blood Research (BPCBR) is simple: to advance research into a wide array of blood and immune disorders, from leukemia to sickle cell disease, by providing Stanford researchers with umbilical cord blood, an invaluable yet often over-looked resource.
Umbilical cord blood is typically disposed of after a baby has been delivered. Advocates of stem cell research have sought an alternative to this approach out of the wish for their child's cord blood to be helpful in treating and curing disease. BPCBR was born from this altruistic desire to advance discovery by bringing patients, clinicians, and researchers together in pursuit of a novel and ambitious endeavor: a non-profit, sustainable initiative that would provide Stanford researchers with umbilical cord blood for years to come.
The Binns Program for Cord Blood Research is a collaborative effort between obstetric providers in the Labor and Delivery (L&D) unit at Lucile Packard Children’s Hospital, Stanford researchers, and other champions of the local community to establish a resource that primarily aims to:
a) Provide interested patients with a means for the post-partum donation of cord blood toward research
b) Develop and implement a standardized system for the collection, processing, and distribution of cord blood components to the Stanford community
c) Further the study of various genetic, hematological and immunological diseases
Jennifer Cory | Director of Strategy & Operations, Center for Definitive and Curative Medicine | (650) 644-5913 | jcory@stanford.edu |
Matthew Porteus, M.D., PhD |
Sutardja Chuk Professor of Definitive and Curative Medicine Director, Center for Definitive and Curative Medicine Director, Stem Cell and Gene Therapy Clinical Trials Program |
(650) 725-6520 | mporteus@stanford.edu |
Deirdre Lyell, M.D. | Dunlevie Endowed Professor of Maternal-Fetal Medicine Associate Director, Division of Maternal-Fetal Medicine and Obstetrics Director, Program in Placental Disorders Medical Director, Labor and Delivery Director, Maternal-Fetal Medicine Fellowship |
dlyell@stanford.edu | |
Rajni Agarwal-Hashmi, M.D. | Professor of Pediatrics Medical Director, Outpatient Clinic and Outreach Pediatric Stem Cell Transplant and Regenerative Medicine |
rajnia@stanford.edu |
Hours | Location | ||||||||
|
|
Name | Role | Phone | Location | |
---|---|---|---|---|
Imene Smati |
Assistant Clinical Research Coordinator
|
(916) 757-9638
|
ismati@stanford.edu
|
Lokey Bldg Suite G2021
|
Grecia Maldonado |
Assistant Clinical Research Coordinator
|
(559) 909-8389
|
grecia28@stanford.edu
|
Lokey Bldg Suite G2021
|
Leah Maltzman |
Assistant Clinical Research Coordinator
|
(610) 513-7239
|
lmaltzm@stanford.edu
|
Lokey Bldg Suite G2021
|